These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39431993)

  • 1. A pH-Sensitive cRGD-PEG-siRNA Conjugated Compound Targeting Glioblastoma.
    Su Q; Chen J; Liu Z; Fan Y; He S
    Bioconjug Chem; 2024 Nov; 35(11):1732-1743. PubMed ID: 39431993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.
    He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A
    Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
    Zhong Y; Wang C; Cheng R; Cheng L; Meng F; Liu Z; Zhong Z
    J Control Release; 2014 Dec; 195():63-71. PubMed ID: 25108151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
    Chen W; Zou Y; Zhong Z; Haag R
    Small; 2017 Feb; 13(6):. PubMed ID: 27865044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
    Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin.
    Liu J; Zhang Y; Chen T; Chen H; He H; Jin T; Wang J; Ke Y
    ACS Appl Mater Interfaces; 2020 Nov; 12(47):52354-52369. PubMed ID: 33196179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors.
    Quader S; Liu X; Chen Y; Mi P; Chida T; Ishii T; Miura Y; Nishiyama N; Cabral H; Kataoka K
    J Control Release; 2017 Jul; 258():56-66. PubMed ID: 28483513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
    Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
    Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.
    Miura Y; Takenaka T; Toh K; Wu S; Nishihara H; Kano MR; Ino Y; Nomoto T; Matsumoto Y; Koyama H; Cabral H; Nishiyama N; Kataoka K
    ACS Nano; 2013 Oct; 7(10):8583-92. PubMed ID: 24028526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy.
    Saraswathy M; Knight GT; Pilla S; Ashton RS; Gong S
    Colloids Surf B Biointerfaces; 2015 Feb; 126():590-597. PubMed ID: 25591850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-functionalized gold nanoparticles for boron neutron capture therapy with the potential to use in Glioblastoma treatment.
    Zhang Z; Wang X; Dai Q; Qin Y; Sun X; Suzuki M; Ying X; Han M; Wei Q
    Pharm Dev Technol; 2024 Oct; 29(8):862-873. PubMed ID: 39286881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The siEGFR nanoplexes for the enhanced brain glioma treatment: Endoplasmic reticulum biomimetic strategy to induce homing effect and non-degradable intracellular transport.
    Tu Q; Xia F; Meng Y; Wang C; Zhang H; Yao H; Fu Y; Guo P; Chen W; Zhou X; Zhou L; Gan L; Wang J; Han G; Qiu C
    Biomed Pharmacother; 2024 Oct; 179():117413. PubMed ID: 39260325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA.
    Liu X; Wang W; Samarsky D; Liu L; Xu Q; Zhang W; Zhu G; Wu P; Zuo X; Deng H; Zhang J; Wu Z; Chen X; Zhao L; Qiu Z; Zhang Z; Zeng Q; Yang W; Zhang B; Ji A
    Nucleic Acids Res; 2014 Oct; 42(18):11805-17. PubMed ID: 25223783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells.
    Lou B; Connor K; Sweeney K; Miller IS; O'Farrell A; Ruiz-Hernandez E; Murray DM; Duffy GP; Wolfe A; Mastrobattista E; Byrne AT; Hennink WE
    Drug Deliv Transl Res; 2019 Jun; 9(3):679-693. PubMed ID: 30972664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and pharmacological evaluation of a novel PEG-cRGD-conjugated irinotecan derivative as potential antitumor agent.
    Huang YQ; Yuan JD; Ding HF; Song YS; Qian G; Wang JL; Ji M; Zhang Y
    Eur J Med Chem; 2018 Oct; 158():82-90. PubMed ID: 30199708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy.
    Yang S; Wang D; Zhang X; Sun Y; Zheng B
    Drug Deliv; 2021 Dec; 28(1):995-1006. PubMed ID: 34042551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.